DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Orlistat
Orlistat
Lifestyle Drugs” for Men and Women
Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and Other Transcription Factors
Cyproterone Acetate in the Management of Polycystic Ovary Syndrome
(12) Patent Application Publication (10) Pub. No.: US 2012/0022039 A1 Schwink Et Al
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
Clinical Pharmacokinetics and Pharmacodynamics CONCEPTS and APPLICATIONS 18048 FM.Qxd 11/11/09 4:31 PM Page Iii
( Anti-Obesity Agents ) Sibutramine Orlistat Rimonabant
INN-Nimet 1 1.4.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara
Pharmacotherapies for Obesity: Past, Current, and Future Therapies
Fewer Opportunties for Companies to Get Fat Off Obesity Products
Xenical, INN-Orlistat
XENICAL, INN-Orlistat
Novel CB1 Receptor Antagonist BAR-1 Modifies Pancreatic Islet Function
Icrs2016 Programme
Luffa Cylindrica
The Toxicological Evaluation of Rimonabant
(12) Patent Application Publication (10) Pub. No.: US 2011/0178134 A1 JAEHINE Et Al
Anti-Obesity Drugs: a Review About Their Effects and Safety
Top View
Reproductive Medicine Network Funded by NICHD
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
XENICAL Can Decrease Cyclosporine Exposure
Rimonabant Adds Appetizing Choice to Slim Obesity Market
Appendix B - Product Name Sorted by Applicant
Conflict of Interest Disclosures
Redalyc.Long-Term Randomized Clinical Trials of Pharmacological
Lantana Camara Var Linn
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Global List of Validated Bioanalytical Assays
Long-Term Care Drug Database System: Drugs by NDC Class Code, Drug Code and Name
Anti-Obesity Drugs: Past, Present and Future
Drug Coverage Guidelines – Oxford Clinical Policy
Effects of Oral Contraceptives on Metabolic Parameters in Adult Premenopausal Women: a Meta-Analysis
Wave 2 Rimonabant Case Study
Discontinuation Due to Adverse Events in Randomized Trials of Orlistat, Sibutramine and Rimonabant
Pharmaabkommen A1 E
Reimbursement Criteria for Frequently Requested Drugs
Criteria-For-Use Checklist for Orlistat (Xenical) VHA Pharmacy Benefits Management Strategic Healthcare Group and Medical Advisory Panel
Xenical (Orlistat) Patient Information
Evaluation of Anti-Obesity Activity of Methanolic Extract of Sapindus Emarginatus by Progesterone Induced Obesity on Albino Mice
Orlistat in Polycystic Ovarian Syndrome Reduces Weight with Improvement in Lipid Profile and Pregnancy Rates
Effects of Orlistat on Serum Androgen Levels Among Iranian Obese Women with Polycystic Ovarian Syndrome
SUTTER HEALTH PLUS FORMULARY Drug List for HMO Members – Effective September 1, 2021
Obesity/Lipids
Obesity an Overview: Genetic Conditions and Recent Developments in Therapeutic Interventions
Annexe I - Substances Pharmaceutiques, Admises En Exonération Des Droits______
Role of Orlistat Combined with Life Style in the Management of Obese Patients with Polycystic Ovarian Syndrome
01 Stockley's Herbal Medicines Interactions PRELIMS 1
Front Matter (PDF)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Pharmacological Modulation of Endocannabinoid System in Pancreatic Islets, a Different Strategy for 007 Prediabetes and Diabetes Treatment
Melt Amorphisation of Orlistat with Mesoporous Silica Using A
Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists
Tepzz 5 58¥Zb T
Total Synthesis of Axially-Chiral Cannabinols: a New Platform for Cannabinoid-Based Drug Discovery
Efficacy of Orlistat in Non‑Alcoholic Fatty Liver Disease: a Systematic Review and Meta‑Analysis
View / Download Pdf Version of This Article
Cannabinoid Signaling
Drug Interactions with Hormonal Contraception Clinical Effectiveness Unit January 2011
National Drugs and Poisons Schedule Committee
New Role of Phenothiazine Derivatives As Peripherally Acting CB1 Receptor Antagonizing Anti-Obesity Agents
PA Drug Name Generic Name PA Summary Name Epaned Enalapril
The New Era of Drug Therapy for Obesity: the Evidence and the Expectations
Treatment of Polycystic Ovarian Syndrome in Primary Care
Anti-Obesity Drugs: a Review About Their Effects and Safety
Obesity Flip Chart Clinician Resource June, 2017 Orlistat (Xenical; Alli)1-2
The Pharmacology of Weight Management
Combined Hormonal Contraception
FDA Briefing Document Pharmacy Compounding Advisory Committee
Cannabidiol (CBD)
Molecular Mechanism of Orlistat Hydrolysis by The
The Effect of Venustat on Sex Hormones and Testicular Tissue in Adult Rats
XENICAL (Orlistat) Is a Lipase Inhibitor for Obesity Management That Acts by Inhibiting the Absorption of Dietary Fats
ICRS2012 PROGRAMME and ABSTRACTS
Non-FDA Approved Medication and Product List